PHRI Peer Review Articles 1999-1993 |
< back
|
1999
|
Ounpuu S, Woolcott DM, Rossi SR. Self-efficacy as an intermediate outcome variable in the Transtheoretical Model: validation of a measurement model for applications to dietary fat reduction. Journal of Nutrition Education 1999; 30:1-7.
|
|
Anand SS. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Pilot Study: Evaluation of a cute and long-term therapies for patients with acute coronary syndromes without ST elevation. American J. of Cardiol 1999 Sep 2; 84(5a):13M-19M.
|
|
Anand SS, Bates S, Ginsberg JS, Levine M, Buller H, Prins M, Haley S, Kearon C, Hirsh J, Gent M. Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin time. Archives of Int Med 1999, Sept. 27; 159(17): 1969-2100.
|
|
Anand SS. Using ethnicity as a classification variable in health research: Perpetuating the myth of biological determinism, serving socio-political agendas, or making valuable contributions to medical sciences? Ethnicity and Health 1999 Dec; 4(4):241-244.
|
|
Gerstein HC, Capes S. Advantages and perceived disadvantages of insulin therapy in patients with type 2 diabests. Can J Diabetes Care 1999; 23 (Supp 1): S93-S96.
|
|
Mann JF, Thoma U, Gerstein HC, Franke J, Lievre M. Antihypertensive therapy in patients with type 2 diabetes mellitus: focus on nephropathy. Advances in Nephrology 1999; 29:241-55.
|
|
Gerstein HC, Reddy SSK, Dawson KG, Yale J-F, Shannon S, Norman G. A Controlled Evaluation of a National Continuing Medical Education Program Designed to Improve Family Physicians' Implementation of Diabetes-Specific Clinical Practice Guidelines. Diabetic Medicine 1999; 16(11):964-969.
|
|
Gerstein HC, Hanna A, Leiter L, MacGregor A, Rowe R. CDA position statement regarding the UKPDS and revision of the diabetes clinical practice guidelines accounting for the UKPDS results. Can J Diabetes Care 1999; 23(1):15-17.
|
|
Emami J, Gerstein HC, Pasutto FM, Jamali F. Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration-dependent. Can J Physiol Pharmacol 1999; 77(2):118-23.
|
|
Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) Trial Investigators. Effects of recombinant hirudin (lepirudin) compared with heparin on preventing death, myocardial infarction, refractory angina and revascularization procedures in patients with acute myocardial ischemia without ST elevation: a randomised trial. Lancet 1999; 353(9151): 429-438.
|
|
Coutinho M, Wang Y, Gerstein HC, Yusuf S . The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22(2): 233-240.
|
|
Gerstein HC, Pais P, Pogue J, Yusuf S . Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study. J Am Coll Card 1999; 33(3): 612-619.
|
|
Enas EA, Yusuf S . Third meeting of the international working group on coronary artery disease in South Asians; 29 March 1998, Atlanta, USA. Indian Heart J 1999; 51: 99-103.
|
|
Lonn EM, Yusuf S . Emerging approaches in preventing cardiovascular disease. BMJ 1999; 318(7194): 1337-1341.
|
|
Sheth T, Nair C, Muller J, Yusuf S . Increased winter mortality from acute myocardial infarction and stroke: the effect of age. J Am Coll Card 1999; 37(7): 1916-1919.
|
|
Lonn EM, Yusuf S. Emerging approaches in cardiovascular prevention. BMJ 1999;318:1337-1341.
|
|
Yusuf S, Lonn E, Bosch J, Gerstein H. Critical appraisal of current and ongoing randomized trials of angiotensin converting enzyme inhibitors. Clin Exp Hypertens 1999;21:835-845.
|
|
Salem K, Mulji A, Lonn E. Echocardiographically guided pericardiocentesis - the current gold standard for the management of pericardial effusion and cardiac tamponade. Can J Cardiol 1999;15:1251-1255.
|
|
Salem K, Lonn E. Contrast echocardiography: development and applications. Perspectives in Cardiology 1999;15:44-48.
|
|
Lonn EM, Yusuf S. Emerging approaches in preventing cardiovascular disease. Western J Med 1999;171:247-252.
|
|
Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S . Cardiovascular and cancer mortality among Canadians of European, South Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. Can Med Assoc J 1999; 161(2): 132-138.
|
|
McKelvie RS, Benedict CR, Yusuf S . Prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction. BMJ 1999; 318: 1400-1402.
|
|
Bart BA, Ertl G, Held P, Kuch J, Maggioni AP, McMurray J, Michelson EL, Rouleau JL, Warner Stevenson L, Swedberg K, Young JB, Yusuf S , Sellers MA, Granger CB, Califf RM, Pfeffer MA for the SPICE investigators. Contemporary management of patients with left ventricular dysfunction: results from the study of patients intolerant of converting enzyme inhibitors (SPICE) registry. Eur Heart J 1999; 20: 1182-1190.
|
|
McKelvie RS, Yusuf S , Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki R, White M, Rouleau J, Latini R, Maggioni A, Young J, Pogue J for the RESOLVD Pilot Study Investigators. Comparison of Candesartan, Enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. Circulation 1999; 100: 1056-1064.
|
|
Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S . Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann of Int Med 1999; 131: 363-375.
|
|
Swedberg K, Pfeffer M, Granger C, Held P, McMurray J, Ohlin G, Olofsson B, Östergren J, Yusuf S for the CHARM-Programme Investigators. Candesartan in heart failure - assessment of reduction in mortality and morbidity (CHARM): rationale and design. J of Cardiac Failure 1999; 5(3): 276-282.
|
|
Yusuf S . Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial. 1999; 84 (supp. M): 20M-25M.
|
|
Piegas LS, Flather M, Pogue J, Hunt D, Varigos J, Avezum A, Anderson J, Keltai M, Budaj A, Fox K, Ceremuzynski L, Yusuf S for the OASIS Registry Investigators. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Registry in patients with Unstable Angina. 1999; 84 (supp. M): 7M-12M.
|
|
Wang Y, Flather M, Yusuf S , Wang YH, Li LX, Wang ZC. Recurrent events in meta-analysis of multiple clinical trials. 1999; 20(6): 495-9.
|
|
Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, Gott JP, Herrmann HC, Marlow RA, Nugent WC, O'Connor GT, Orszulak TA, Rieselbach RE, Winters WL, Yusuf S , Gibbons RJ, Alpert JS, Garson Jr A, Gregoratos G, Russell RO, Smith SC. ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). J Am College Card 1999; 34(4): 1262-1347.
|
|
Anand SS, Kundi A, Eikelboom J, Yusuf S , Low rates of preventive practices in patients with peripheral vascular disease. Can J Card 1999; 15(11): 1259-1263.
|
|
Anand S, Yusuf S . Oral anticoagulant therapy in patients with coronary artery disease - a meta-analysis. JAMA 1999; 282(21): 2058-2067.
|
1998
|
Anand SS, Yusuf S, Vuksan V, Devanesen S, Montague P, Kelemen L, for the SHARE Investigators. The Study of Health Assessment and Risk in Ethnic groups (SHARE): cardiovascular risk factors in Canada's ethnic groups. Canadian Cardiovascular Society 51st annual meeting. October 20-24, 1998, Ottawa. Can J Cardiol 1998 Vol 14 (Supp F): 94F
|
|
Kwan T, Gerstein HC, Leber B, Ahuja S, Carter R. Patients with Type 2 Diabetes Have a High Frequency of the C282Y Mutation of the Hemochromatosis Gene. Clin Invest Med 1998; 21(6):251-257.
|
|
Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, Yale JF, Zinman B, Lillie D, Steering and Expert Committees. 1998 clinical practice guidelines for the management of diabetes in Canada. Can Med Asoc J 1998; 159(8 Suppl): S1-S29.
|
|
Gerstein HC. Dysglycemia - a cardiovascular risk factor. Diabetes Research and Clinical Practice 1998; 40 Suppl: S9-14.
|
|
Pogue J, Yusuf S . Overcoming the limitations of current meta-analysis of randomised controlled trials. The Lancet 1998; 351:47-52.
|
|
Anand SS, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S . Elevated lipoprotein(a) levels in South Asians in North America. Metabolism 1998;47(2):182-184.
|
|
Reddy KS, Yusuf S . Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97(6):596-601.
|
|
Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, Mottard I, Woods P, Niewiecki M, Yusuf S for the SOLVD Investigators. Predicting mortality and hospitalization in 5025 patients with heart failure utilizing baseline quality of life. CHF 1998 (Jan/Feb): 31-37.
|
|
Sheth T, Nargundkar M, Chagani K, Anand S, Nair C, Yusuf S . Classifying ethnicity utilizing the Canadian mortality database. Ethnicity & Health 1998; 2(4):287-295.
|
|
World Health Organization - International Society of Hypertension Blood Pressure Lowering Treatment Trialists= Collaboration. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. J Hypertension 1998; 16: 127-137.
|
|
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-q-wave myocardial infarction. N Engl J of Med 1998;338:1488-1497.
|
|
Yusuf S, Lonn E. Anti-ischemic effects of ACE-inhibitors: review of current clinical evidence and ongoing clinical trials. Eur Heart J 1998;19(Suppl J):J36-J44.
|
|
Lonn EM. Emerging approaches in the prevention of atherosclerotic cardiovascular diseases. Int J Clinical Practice 1998;Suppl 94:7-19.
|
|
Yusuf S . The global problem of cardiovascular disease. International J of Clinical Practice 1998; Supplement 94: 3-6.
|
|
Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R, on behalf of the ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 1998; 316: 1337-1343.
|
|
Sheth TB, Nair CM, Yusuf S . Contrasting rates of heart disease and lung cancer among South Asians, Chinese, and European Canadians examined in an international context. CVD Prevention 1998; 1: 19-24.
|
|
Enas EA, Yusuf S , Sharma S. Coronary artery disease in South Asians: Second meeting of the International Working Group, March 16, 1997, Anaheim, California. Indian Heart J 1998; 50(1):105-113.
|
|
ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100 000 patients in randomized trials. Circulation 1998; 97: 2202-2212.
|
|
Yusuf S , Flather M, Pogue J, Hunt D, Varigos J, Piegas L, Avezum A, Anderson J, Keltai M, Budaj A, Fox K, Ceremuzynski L, for the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry Investigators. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998; 352: 507-514.
|
|
Yusuf S , Lonn E. Anti-ischemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials. Eur Heart J 1998; 19 (Supp. J): J36-J44.
|
|
Anand SS, Yusuf S , Pogue J, Weitz JI, Flather M, for the OASIS Pilot Study Investigators. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: Organization to Assess Strategies for Ischemic Syndromes (OASIS) pilot study results. Circulation 1998; 98(11): 1064-1070.
|
|
Kronenberg MW, Konstam MA, Edens TR, Howe DM, Dolan N, Udelson JE, Benedict C, Stewart D, Yusuf S for the SOLVD Investigators. Factors influencing exercise performance in patients with left ventricular dysfunction. J Card Failure 1998; 4(3): 159-167.
|
|
Avezum Á, Tsuyuki RT, Pogue J, Yusuf S . Beta blocker therapy for congestive heart failure: a systematic overview and critical appraisal of the published trials. Can J of Cardiology 1998; 14(8): 1045-1053.
|
|
Anand SS, Yusuf S , Vuksan V, Devanesen S, Montague P, Kelemen L, Bosch J, Sigouin C, Teo KK, Lonn E, Gerstein HC, Hegele RA, McQueen M, for the SHARE Investigators. The study of health assessment and risk in ethnic groups (SHARE): rationale and design. Can J Cardiol 1998;14(11): 1349-1357.
|
1997
|
Gerstein HC. Glucose - A continuous risk factor for cardiovascular disease. Diabetic Medicine 1997; 14 (Supp 3): S25-S31.
|
|
Okamoto T, Gerstein HC, Obara T. Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism; A systematic overview of the literature. Endocrine Journal 1997; 44(3):367-374.
|
|
Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systematic overview of the literature. Arch Int Med 1997; 157:1413-1418.
|
|
The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997; 336(3): 153-162.
|
|
Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J of Hypertension 1997; 15:105-115.
|
|
Patten RD, Kronenberg MD, Benedict CR, Udelson JE, Kinan D, Stewart D, Yusuf S , Smith JJ, Kilcoyne L, Dolan N, Edens TR, Howe DM, Metherall J, Konstam MA. Acute and long-term effects of the angiotensin converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction. Am Heart J 1997:134(1):37-43.
|
|
Flather M, Farkouh ME, Pogue JM, Yusuf S . Strengths and limitations of meta-analysis: larger studies may be more reliable. Cont Clin Trials 1997;18(6):568-579.
|
|
Pogue JM, Yusuf S . Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Cont Clin Trials 1997; 18(6):580-593.
|
|
Anand SS, Brimble S, Ginsberg JS. Management of iliofemoral thrombosis in a pregnant patient with heparin esistance. Archives of Internal Medicine 1997; 157(7): 815-816.
|
|
Anand SS, Yusuf S. Risk Factors for cardiovascular disease in Canadians of South Asian and European origin: A pilot study of the Study of Heart Assessment and Risk in Ethnic groups (SHARE). Clinical and Investigative Medicine 1997; 20(4): 204-210.
|
|
Anand S, Ginsberg JS, Hirsh J. Is there a relationship between the intensity of heparin treatment and recurrent thromboembolism? Clin Appl Thrombosis/Haemostasis 1997;3(Suppl.1):S64-S67.
|
|
Lonn EM, Yusuf S. Is There a Role for Antioxidant Vitamins in the Prevention of Cardiovascular Diseases? An Update on Epidemiologic and Clinical Trials Data. Can J Cardiol 1997;13:957-965.
|
|
Yusuf S . Meta-analysis of randomized trials: looking back and looking ahead. Cont Clin Trials 1997; 18(6): 594-601.
|
|
The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.
|
|
Anand SS, Pais P, Pogue J, Yusuf S . A comparison of practice patterns for acute myocardial infarction between hospitals in Canada and India. Indian Heart Journal 1997;49:35-41.
|
|
Collaborative Organization for RheothRx Evaluation (CORE) Investigators. Effects of RheothRx on mortality, morbidity, left ventricular function and infarct size in patients with acute myocardial infarction. Circulation 1997;96:192-201.
|
|
Yusuf S . Pathophysiology and management of patients with acute ischaemic syndromes: some perspectives. Int J of Clin Practice 1997;90(June supp.):1-6.
|
|
Organization to Assess Strategies for Ischemic Syndromes (OASIS) investigators. Comparison of the effects of two doses of recombinant hirudin compared to heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Circulation 1997;96(3):769-777.
|
|
Lonn EM, Yusuf S . Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiologic and clinical trials data. Can J of Card 1997;13(10):957-965.
|
|
Toth K, Bogar L, Juricskay I, Keltai M, Yusuf S , Haywood LJ, Meiselman HJ. The effect of RheothRx injection on the hemorheological parameters in patients with acute myocardial infarction. Clinical Hemorheology and Micro Circulation 1997; 17(2):117-125.
|
|
Anand SS, Yusuf S . Risk factors for cardiovascular disease in Canadians of South Asian and European origin: a pilot study of the Study of Heart Assessment and Risk in Ethnic Groups (SHARE). Clin Invest Med 1997; 20(4):204-210.
|
|
Tsuyuki RT, Yusuf S , Rouleau JL, Maggioni AP, McKelvie RS, Wiecek EM, Wang Y, Pogue J, Teo KK, White M, Avezum Á, Latini R, Held P, Lindgren E, Probstfield J, for the RESOLVD Pilot Study Investigators. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists, and beta blockers in patients with congestive heart failure: design of the randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. Can J of Card 1997;13(12):1166-1174.
|
1996
|
Gerstein HC, VanderMeulen J. The relationship between cow's milk exposure and type 1 diabetes. Diabetic Medicine 1996; 13:23-29.
|
|
Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, Harper S, Griffith L, Carbotte R. Does treatment with L-thyroxine influence health status in older adults with subclinical hypothyroidism? Results of a randomized, double blind, placebo controlled trial. J Gen Int Med 1996; 11:744-749.
|
|
Weiss RE, Tunca H, Gerstein HC, Refetoff S. A new mutation in the thyroid hormone receptor (TR) gene (V458A) in a family with resistance tothyroid hormone (RTH). Thyroid 1996; 6(4):311-312.
|
|
VanderMeulen J, Gerstein HC. Understanding the link between cow's milk protein and type 1 diabetes mellitus. Practical Allergy and Immunology 1996; 11:22-27.
|
|
Enas E, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S . Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart Journal 1996; 48: 343-353.
|
|
The HOPE Study Investigators. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996; 12(2): 127-137.
|
|
Gerstein HC, Yusuf S . Dysglycaemia and risk of cardiovascular disease. Lancet 1996; 347(9006): 949-950.
|
|
Yusuf S, Anand SS. The cost of prevention: the case of lipid lowering. Circulation 1996; 93:1774-76.
|
|
Anand SS, Ginsberg JS, Kearon C, Gent M, Hirsh J. The relationship between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. Archives Internal Medicine 1996; 156 (August 12):1677-1681.
|
|
Yusuf S, Anand SS, Avezum Jr. A, Flather M, Coutinho M, Pais P. Treatment for acute myocardial infarction: overview of randomized clinical trials. European Heart Journal 1996; 17 (Supp F): 16-29.
|
|
The HOPE Investigators: The HOPE (Heart Outcomes Prevention Evaluation) study. The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996;12(2):127-137.
|
|
Venkatesh R, Lonn E, Holder D, Williams WG, Mulji A. Acquired left ventricular to right atrial communication with complete heart block, following non-penetrating cardiac trauma. Can J Cardiol 1996;12(4):349-352.
|
|
Lonn E, Tsuyuki R, Yusuf S. Drug therapy for secondary prevention of reinfarction and sudden cardiac death. Topics in Preventive Cardiology. Exerpta Medica, Amsterdam 1996:1-31.
|
|
Lonn E, Yusuf S, Doris CI, et al., for the SECURE Investigators. Study design and baseline characteristics of the Study to Evaluate Carotid Ultrasound Changes in patients treated with Ramipril and vitamin E: SECURE. Am J Cardiol 1996;78:914-919.
|
|
Gerstein HC, Bosch B, Pogue J, Taylor DW, Zinman B, Yusuf S, for the HOPE Investigators. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. Diabetes Caree 1996; 19:1225-1228.
|
|
The Digitalis Investigation Group. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Cont Clin Trials 1996 17:77-97.
|
|
Pais P, Pogue J, Gerstein H, Zachariah E, Savitha D, Jayprakash S, Nayak PR, Yusuf S . Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet 1996; 348(August 10): 358-363.
|
|
Venkatesh G, Fallen EL, Kamath MV, Connolly S, Yusuf S . Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure. Heart 1996; 76:137-143.
|
|
Shindler DM, Kostis JB, Yusuf S , Quinones MA, Pitt B, Stewart D, Pinkett T, Ghali JK, Wilson AC, for the SOLVD Investigators. Diabetes mellitus, a predictor of morbidity and mortality in the Studies Of Left Ventricular Dysfunction (SOLVD) trials and registry. Am J Card 1996; 77(May 1): 1017-1020.
|
|
Connolly SJ, Kerr C, Gent M, Yusuf S . Dual-chamber versus ventricular pacing: critical appraisal of current data. Circulation 1996; 94(August 1): 578-583.
|
|
Flather MD, Farkouh ME, Avezum Á, Yusuf S . Importance of large simple trials in cardiovascular disease. Rev Soc Cardiol Estado De São Paulo [Journal of the São Paulo Society of Cardiology] 1996;6(3):271-279.
|
|
McKelvie R, Tsuyuki RT, Yusuf S . Evidence-based recommendations for the management of congestive heart failure. Rev Soc Cardiol Estado De São Paulo [Journal of the São Paulo Society of Cardiology] 1996;6(3):337-356.
|
|
Collins R, MacMahon S, Flather M, Baigent C, Remvig L, Mortensen S, Appleby P, Godwin J, Yusuf S , Peto R. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomized trials. BMJ 1996; 313(Sept. 14): 652-659.
|
|
Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S , the HOPE study investigators. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE-inhibitor and Vitamin E in high-risk patients with diabetes: the MICRO-HOPE study. Diabetes Care , 1996: 19(11): 1225-1228.
|
|
Lonn EM, Yusuf S , Doris CI, Sabine M, Dzavik V, Hutchinson K, Riley WA, Tucker J, Pogue J, Taylor W, for the SECURE Investigators. Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE. Am J Cardiol 1996; 78: 914-919.
|
|
Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S , for the SOLVD investigators. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94 (Aug 15):690-697.
|
|
Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, Mottard I, Woods P, Konstam MA, Yusuf S , for the SOLVD investigators. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. Am J Cardiol 1996; 78: 890-895.
|
|
Enas EA, Yusuf S , Mehta J. Meeting of the International Working Group on Coronary Artery Disease in South Asians: 24 March 1996, Orlando, Florida, USA. Indian Heart Journal 1996; 48: 727-732.
|
1995
|
Ferguson EL, Gibson RS, Opare-Obisaw C, Ounpuu S, Lamba C. Dietary strategies for improving the zinc nutriture of rural, southern Malawian and Ghanaian children. Ecology of Food and Nutrition. 1995;34:33-47.
|
|
Strauss BH, Robinson R, Batchelor WB, Chisholm RJ, Ravi G, Natarajan M, Logan RA, Mehta SR, Levy DE, Ezrin AM, Keeley FW. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circulation Res 1996;79(3):541-550.
|
|
Gerstein HC, Simpson JR, Atkinson SA, Taylor DW, VanderMeulen J. Feasibility and acceptability of a proposed infant feeding intervention trial for the prevention of type 1 diabetes. Diabetes Care 1995;18:940-942.
|
|
Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ, Evidence-Based Medicine Working Group. Users' guides to the medical literature. IX. A method for grading health care recommendations. JAMA 1995;274:1800-1804.
|
|
Michels KB, Yusuf S . Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995; 91:476-485.
|
|
Young JB, Weiner DH, Yusuf S , Pratt CM, Kostis JB, Weiss MB, Schroeder E, Guillote M for SOLVD Investigators. Patterns of medication use in patients with heart failure: A report from the Registry of Studies Of Left Ventricular Dysfunction (SOLVD). Southern Med J 1995; 88(5): 514-523.
|
|
Kirlin PC, Benedict C, Shelton BJ, Francis G, Nicklas J, Liang CS, Kubo S, Johnstone D, Probstfield J, Yusuf S for the SOLVD Investigators. Neurohumoral variability in left ventricular dysfunction. Am J Cardiol 1995; 75(February 15): 354-359.
|
|
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345(8951): 669-685.
|
|
Clausell N, Butany J, Molossi S, Lonn E, Gladstone P, Rabinovitch M, Daly P. Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries. J Am Coll Cardiol 1995;26:110-9.
|
|
Flather MD, Lonn EM, Yusuf S. Effects of angiotensin converting enzyme inhibitors on mortality when started in the early phase of myocardial infarction: evidence from the larger randomized controlled trials. J Cardiovasc Risk 1995;2:423-428.
|
|
Rihal CS, Flather M, Hirsh J, Yusuf S . Advances in antithrombotic drug therapy for coronary artery disease. Eur Heart J 1995; 16(Supplement D): 10-21.
|
|
Benedict CR, Francis GS, Shelton B, Johnstone DE, Kubo SH, Kirlin P, Nicklas J, Liang C-S, Konstam MA, Greenberg B, Yusuf S , for the SOLVD Investigators. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. Am J Cardiol 1995; 75: 1151-1157.
|
|
Pratt CM, Gardner M, Pepine C, Kohn R, Young JB, Greenberg B, Capone R, Kostis J, Henzlova M, Gosselin G, Weiss M, Francis M, Stewart D, Davis E, Yusuf S for the SOLVD Investigators. Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure. Am J Cardiol 1995; 75(June 15):1244-1249.
|
|
Avezum Jr. A, Pais P, Flather M, Anand SS, Yusuf S. Pharmacological treatment for myocardial infarction part 1: implications of clinical trials of thrombolytic and anti-thrombotic therapies. Indian Heart J. 1995; 47:3-11.
|
|
Avezum Jr. A, Pais P, Flather M, Anand SS, Yusuf S. Pharmacological treatment for myocardial infarction part 2: implications of clinical trials of other adjunctive therapies. Indian Heart J 1995; 47:95-105.
|
|
The Canadian Cardiovascular Collaboration. Collaborative cardiovascular clinical trials in Canada. Can J Cardiol 1995; 11(8):649-657.
|
|
Cholesterol Treatment Trialists' (CTT) Collaboration. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Am J Cardiol 1995; 75: 1130-1134.
|
|
Garg R, Yusuf S , for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273(18): 1450-1456.
|
|
Jha P, Flather M, Lonn E, Farkouh M, Yusuf S . The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123: 860-872.
|
1994
|
Rogers WJ, Johnstone DE, Yusuf S , Weiner DH, Gallagher P, Bittner VA, Ahn S, Schron E, Shumaker SA, Sheffield LT, for the SOLVD Investigators. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The Studies of Left Ventricular Dysfunction. J Am Coll Card 1994;23(2):393-400.
|
|
Benedict CR, Johnstone DE, Weiner DH, Bourrassa MG, Bittner V, Kay R, Kirlin P, Greenberg B, Kohn RM, Nicklas JM, McIntyre K, Quinones MA, Yusuf S , for the SOLVD Investigators. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the Registry of Studies of Left Ventricular Dysfunction. J Am Coll Card 1994;23(6):1410-1420.
|
|
McKelvie R, McConachie D, Yusuf S . Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. Eur Heart J 1994;15(Suppl B):9-13.
|
|
Yusuf S , Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R, Morris C, Mathur V, Varnauskas E, Chalmers TC. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344(8922): 563-570.
|
|
Yusuf S , Zucker D, Chalmers TC. Ten-year results of the randomized controlled trials of coronary artery bypass graft surgery: tabular data compiled by the collaborative effort of the original trial investigators. Part 1 of 2. Online J of Curr Clin Trials , Doc No 144, Oct 14, 1994.
|
|
Yusuf S , Zucker D, Chalmers TC. Ten-year results of the randomized control trials of coronary artery bypass graft surgery: tabular data compiled by the collaborative effort of the original trial investigators. Part 2 of 2. Online J of Curr Clin Trials , Doc No 145, Oct 15 1994.
|
|
Lonn EM, Yusuf S , Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994; 90(4): 2056-2069.
|
|
Lonn E, Factor SM, Wen WH, van Hoeven KH, Dawood F, Liu P: Effect of oxygen free radicals and scavengers on myocardial collagen during ischemia-reperfusion. Can J Cardiol 1994;10:203-213.
|
|
Jaeschke R, Guyatt GH, Cook D, Harper S, Gerstein HC. Spectrum of quality of life impairment in hypothyroidism. Quality of Life Research 1994; 3:323-327.
|
|
Gerstein HC. Cow's milk exposure and type 1 diabetes mellitus. A critical overview of the clinical literature. Diabetes Care 1994; 1:13-19.
|
|
Gerstein HC. Screening for postpartum thyroid dysfunction. Comp Ther 1994; 20(6):331-335.
|
|
Lonn E, Yusuf S, Jha P, Montague T, Teo K, Benedict CR, Pitt B: The emerging role of angiotensin converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994;90:2056-2069.
|
|
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308(January 8): 81-106.
|
|
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft of arterial patency by antiplatelet therapy. BMJ 1994; 308(January 15): 159-168.
|
|
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308(January 12):235-246.
|
|
Dorian P, Connolly S, and Yusuf S . The impact of left ventricular dysfunction on outcomes with the implantable defibrillator. Am Heart J 1994; 127: 1159-1163.
|
|
Kostis JB, Shelton BJ, Yusuf S , Weiss MB, Capone RJ, Pepine C, Gosselin G, Delahaye F, Probstfield JL, Cahill L, Dutton D, for the Studies Of Left Ventricular Dysfunction Investigators. Tolerability of enalapril initiation by patients with left ventricular dysfunction: Results of the medication challenge phase of the Studies of Left Ventricular Dysfunction. Am Heart J 1994; 128: 358-64.
|
|
Johnstone DE, Abdulla A, Arnold JMO, Bernstein V, Bourassa M, Brophy J, Davies R, Gardener M, Hoeschen R, Mickleborough L, Moe G, Montague T, Paquet M, Rouleau JL, Yusuf S . Diagnosis and management of heart failure. Can J Cardiol 1994; 10(6):613-31.
|
|
Johnstone DE, Abdulla A, Arnold JMO, Bernstein V, Bourassa M, Brophy J, Davies R, Gardener M, Hoeschen R, Mickleborough L, Moe G, Montague T, Paquet M, Rouleau JL, Yusuf S . Diagnosis and management of heart failure. Can J Clin Pharmacol 1994; 1(3/4): 105-123.
|
1993
|
Yusuf S, Garg R. Design, results and interpretation of randomized controlled trials in congestive heart failure and left ventricular dysfunction. Circulation 1993;87(Supp VII):VII-115-VII-121.
|
|
Yusuf S, Lessam D, Jha P, Lonn E: Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials. Hypertension 1993;Suppl 4:S61-S73.
|
|
Garg R, Yusuf S. Current and ongoing randomized trials in heart failure and left ventricular dysfunction. J Am Coll Card 1993;22(4 Suppl A):194A-197A.
|
|
Montague TJ, Yusuf S , Tsuyuki RT, Teo KK. Importance of preventing ischemia in patients with congestive heart failure. Can J Cardiol 1993;9(Suppl F):39F-43F.
|
|
Teo KK, Yusuf S , Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993;270(13):1589-1595.
|
|
Bittner V, Weiner DH, Yusuf S , Rogers WJ, McIntyre KM, Bandiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillote M, Greenberg B, Woods PA, Bourassa MG, for the SOLVD Investigators. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 1993;270(14):1702-1707.
|
|
Pouleur H, Rousseau MF, van Eyll C, Melin J, Youngblood M, Yusuf S , for the SOLVD Investigators. Cardiac mechanics during development of heart failure. Circulation 1993;87(5 Supp IV):IV14-IV20.
|
|
Benedict CR, Weiner DH, Johnstone DE, Bourassa MG, Ghali JK, Nicklas J, Kirlin P, Greenberg B, Quinones MA, Yusuf S, for the SOLVD Investigators. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. J Am Coll Card 1993;22(4 Suppl A):146A-153A.
|
|
Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, Howe DM, Kilcoyne L, Metherall J, Benedict C, Yusuf S , Pouleur H, for the SOLVD Investigators. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. Circulation 1993;88(Part 1):2277-2283.
|
(Back to top)
|
